Recovery & Repair

Klow Blend UAE: BPC-157, TB-500, KPV and GHK-Cu Research Stack Guide (2026)

· · 5 min read
Klow Blend UAE: BPC-157, TB-500, KPV and GHK-Cu Research Stack Guide (2026)
💡What You’ll Learn
  • Key Facts at a Glance
  • What Is the Klow Blend?
  • Formulation per vial
  • Why KPV is in this blend
  • Full mechanism overview
🔄 Last updated: June 24, 2026
5 min read|1,087 words
!
Research Use Only

For laboratory research and development purposes. Not for human consumption. Not approved for therapeutic use.

For researchers who need the Glow Blend repair-and-matrix core plus KPV in one reconstitution, the Klow Blend from Emirates Peptides combines four research peptides in a fixed ratio: BPC-157, TB-500, KPV, and GHK-Cu at 10 mg / 10 mg / 10 mg / 50 mg80 mg total per vial.

Klow is not a stronger Glow. BPC-157, TB-500, and GHK-Cu amounts match Glow exactly; Klow adds 10 mg KPV. For full formulation, QC, and procurement comparison, read the Glow vs Klow comparison guide.

Research blends Glow Blend AED 620 Klow Blend AED 780 Compare blends →
Glow vs Klow formulation comparison chart
Klow adds 10 mg KPV to Glow’s 10/10/50 core — 80 mg total.

02 · Klow

What Is the Klow Blend?

TL;DR. Glow’s three-peptide core + 10 mg KPV. Four peptides, 80 mg total — a variant, not an upgrade.

The Klow Blend is a four-peptide pre-blended research vial with fixed masses:

Item 01

BPC-157 — 10 mg:

Repair signalling, angiogenesis, soft-tissue models

Item 02

TB-500 — 10 mg:

Cell migration, actin-related repair pathways

Item 03

KPV — 10 mg:

Anti-inflammatory tripeptide (Lys-Pro-Val) studied in gut and NF-κB models

Item 04

GHK-Cu — 50 mg:

Matrix remodelling, collagen-related readouts

03 · Formulation

Formulation per vial

📬
Stay Updated on Peptide Research

Latest research insights. No spam, ever.

Peptide mass composition — Klow (80 mg)

Four-peptide blend80 mg
BPC
TB
KPV
GHK-Cu
GHK-Cu KPV (Klow only) BPC / TB
ComponentMassIn Glow?
BPC-15710 mgYes — same
TB-50010 mgYes — same
KPV10 mgKlow only
GHK-Cu50 mgYes — same
Total80 mgGlow = 70 mg (no KPV)

04 · Blend

Why KPV is in this blend

Compound 01

BPC-157

Same repair core as Glow.

10 mg
Compound 02

TB-500

Same migration axis as Glow.

10 mg
Compound 03

GHK-Cu

Same matrix peptide as Glow.

50 mg
Compound 04

KPV

Inflammatory-modulation axis — the only addition vs Glow.

10 mg · Klow only

June 2026 procurement note: Klow Blend (SKU EP-BPC1572, 80 mg per vial) is listed at AED 780. QC should resolve four HPLC peaks (BPC-157, TB-500, GHK-Cu, KPV) — not three. If your model does not need KPV in the same reconstitution, the three-peptide Glow Blend is the simpler stack.

+10

mg KPV vs Glow

Same BPC, TB, and GHK-Cu as Glow. Klow adds KPV and 10 mg total mass — a variant for models that need an inflammatory axis in one reconstitution, not a potency upgrade.

TL;DR. KPV adds a parallel inflammatory-modulation axis. It does not replace BPC or TB — it extends the stack when your endpoints need it in the same vial.

KPV (Lysine-Proline-Valine) is a short tripeptide investigated in preclinical models of intestinal inflammation, gut-barrier permeability, and NF-κB pathway modulation. Researchers who would otherwise buy standalone KPV alongside Glow may prefer Klow for one reconstitution — at the cost of a fourth analytical target on incoming QC.

  • Studied in colitis and intestinal inflammation rodent models
  • NF-κB-related inflammatory signalling in preclinical literature
  • Complements BPC-157’s repair framing through a distinct mechanism family

05 · Mechanism

Full mechanism overview

Four peptide mechanism infographic — Glow vs Klow pathways
KPV adds a fourth inflammatory-modulation axis on the Glow core.
ComponentMassPrimary mechanismTypical research framing
BPC-15710 mgRepair signalling, angiogenesisSoft-tissue injury models
TB-50010 mgCell migrationWound-healing kinetics
KPV10 mgInflammatory modulationGut-barrier, IBD-adjacent models
GHK-Cu50 mgMatrix remodellingCollagen, fibroblast assays
Decision flowchart — Glow or Klow for your research model
Choose Klow only when KPV belongs in the same reconstitution.

06 · Klow

Klow vs Glow: which to choose?

Decision rule. If your model does not need KPV, order Glow (simpler QC, 70 mg). If it does, order Klow or run parallel singles for attribution. Full comparison →
FactorGlow BlendKlow Blend
Peptides34
Total mass70 mg80 mg
BPC / TB / GHK10 / 10 / 50 mg10 / 10 / 50 mg (identical)
KPV10 mg
QC complexity3 peaks4 peaks
Default pickRepair + matrix without KPVRepair + matrix + KPV in one vial

07 · Reconstitution

Reconstitution and storage

Research use only. Total mass is 80 mg vs Glow’s 70 mg — adjust concentration math if you use the same diluent volume. Not dosing guidance.

Reconstitute with bacteriostatic water. Use our peptide calculator for aliquot math. GHK-Cu dominates mass — swirl gently, protect from light, refrigerate after reconstitution.

Storage

Item 01

Lyophilised:

2–8 °C, protect from light

Item 02

Reconstituted:

2–8 °C per your validated SOP

Item 03

UAE arrival:

Same-day refrigerator storage mandatory in summer months

08 · Klow

Where to buy Klow Blend in the UAE

  • Pre-blended 10/10/10/50 mg per vial — COA per batch
  • Per-peptide identity on certificate of analysis
  • Same-day UAE dispatch when in stock
  • GCC shipping available

Order Klow Blend → · Compare with Glow Blend →

09 · Questions

Frequently Asked Questions

What’s the difference between Klow and Glow? +
Glow = BPC-157 + TB-500 + GHK-Cu (70 mg). Klow = same three at the same masses + 10 mg KPV (80 mg). Klow is a variant with KPV added, not a higher-tier Glow.
Is Klow just an upgraded Glow? +
No. BPC, TB, and GHK-Cu amounts are identical. You gain KPV and 10 mg additional total mass. Choose Klow only when your model needs KPV in the same reconstitution.
What does KPV add that BPC-157 does not? +
KPV is studied as an anti-inflammatory tripeptide in gut and NF-κB models — a different mechanism family from BPC-157’s repair-signalling literature. They are complementary, not redundant.
When is Klow the right SKU? +
When your protocol needs KPV alongside BPC/TB/GHK in one vial — intestinal inflammation models, barrier permeability readouts, or when you would otherwise reconstitute KPV separately. See the comparison guide for decision detail.
Is Klow harder to validate on incoming QC? +
Yes. Klow introduces a fourth HPLC peak. Methods developed for Glow’s three components need a KPV retention assignment before lot release.
Is Klow Blend legal in the UAE for research? +
All four components are supplied strictly for laboratory research. They are not approved medicines and are not positioned for human therapeutic use.

10 · References

References

  1. Sikiric P et al. Stable gastric pentadecapeptide BPC 157. Curr Pharm Des. PubMed
  2. Goldstein AL et al. Thymosin beta-4. Ann NY Acad Sci. PubMed
  3. Brzoska T et al. KPV anti-inflammatory tripeptide. Endocr Rev. PubMed
  4. Kannengiesser K et al. KPV inhibits inflammatory signaling in intestinal epithelial cells. PLoS One. PubMed
  5. Dalmasso G et al. KPV uptake reduces intestinal inflammation. Gastroenterology. PubMed
  6. Pickart L, Margolina A. GHK-Cu regenerative actions. Int J Mol Sci. PubMed

Disclaimer: For laboratory research use only. Not approved for human use. Not medical advice.

Was this article helpful?

Emirates Peptides Research Team

Emirates Peptides Research Team curates evidence-based content on peptide science for research professionals across the UAE and beyond.

Share this article

Emirates Peptides Research Team

Scientific Content

Our research team curates evidence-based content on peptide science, ensuring all articles are grounded in peer-reviewed literature and current scientific understanding. All products are for laboratory research use only.

Explore Research-Grade Peptides

HPLC-verified, lab-tested peptides for your scientific research. Fast delivery across the UAE.

Browse All Peptides
Reviewer
Medical Reviewer

Emirates Peptides Research Team

A dedicated coalition of biochemists and clinical researchers focusing on advanced peptide synthesis and pharmacological applications. All data is verified against current clinical trials.